デフォルト表紙
市場調査レポート
商品コード
1578204

遺伝子発現解析の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年~2032年の予測

Global Gene Expression Analysis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032


出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
遺伝子発現解析の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年~2032年の予測
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子発現解析市場の世界需要は、2023年の211億米ドルから2032年には343億9,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは5.58%です。

遺伝子発現解析(GEA)は、生物学的システムの挙動を調査するためにデータを抽出する方法です。遺伝子発現解析は、タンパク質の転写、RNAスプライシング、翻訳、翻訳後修飾といった様々なステップを組み合わせて行われます。このプロセスは、遺伝子発現パターンの変化が生物学的プロセスの違いをもたらす、生物学的活性の鋭敏な指標と見なされます。GEAは分子生物学研究において効果的なツールであることが証明されており、遺伝子の機能を理解し、病気を診断し、医薬品開発に役立てるために使用されています。

市場力学

個別化医療へのニーズの高まりは、予測期間中、世界の遺伝子発現解析市場に影響を与える可能性が高いです。また、関連プログラムへの資金提供の増加は、今後数年間の市場成長を促進すると推定されます。さらに、世界のがん患者の増加により、遺伝子発現解析の需要と応用が増加しています。世界の遺伝子発現解析市場の成長に影響を与えそうなもう1つの重要な要因は、研究室での研究が重視されていることです。創薬と市場開拓は、市場成長に有利な成長機会を提供しそうな他の要因です。さらに、ゲノミクスの方向性を示す政府資金の増加が、市場成長率をさらに押し上げています。しかし、熟練労働者の不足、認識不足、機器の高コストなどの要因が市場成長の妨げになる可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは遺伝子発現解析の世界市場における各セグメントを包括的に評価することもできます。遺伝子発現解析産業の成長と動向は、この調査に全体的なアプローチを提供します。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 遺伝子発現解析- 産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 遺伝子発現解析の世界市場分析:プロセス別

  • 概要
  • 実績および予測データ分析
  • サンプル採取
  • 精製
  • CDNA合成・変換
  • PCR分析
  • データ解析と解釈

第6章 遺伝子発現解析の世界市場分析:製品別

  • 概要
  • 実績および予測データ分析
  • キット&試薬
  • DNAチップ
  • その他

第7章 遺伝子発現解析の世界市場分析:容量別

  • 概要
  • 実績および予測データ分析
  • 低・中プレックス
  • 高プレックス

第8章 遺伝子発現解析の世界市場分析:用途別

  • 概要
  • 実績および予測データ分析
  • 創薬・医薬品開発
  • 臨床診断
  • バイオテクノロジーと微生物学
  • その他

第9章 遺伝子発現解析の世界市場分析:技術別

  • 概要
  • 実績および予測データ分析
  • RNA発現
  • プロモーター解析
  • タンパク質発現・翻訳後修飾解析

第10章 遺伝子発現解析の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • セグメント別
    • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第11章 遺伝子発現解析企業の競合情勢

  • 遺伝子発現解析市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Qiagen
  • Quest Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • GE Healthcare
  • Promega Corp.
  • Luminex Corp.
  • Takara Bio Inc.
  • Danaher Corp.
  • ELITechGroup
  • AutoGenomics
  • Biocartis NV
  • IntegraGen
  • Interpace Biosciences Inc.
  • Fluidigm Corp
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Process (USD MN)
  • Sample Collection Market Sales By Geography (USD MN)
  • Purification Market Sales By Geography (USD MN)
  • CDNA synthesis & conversion Market Sales By Geography (USD MN)
  • PCR Analysis Market Sales By Geography (USD MN)
  • Data analysis & interpretation Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • DNA Chips Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Capacity (USD MN)
  • Low- to Mid- Plex Market Sales By Geography (USD MN)
  • High-Plex Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Clinical Diagnostics Market Sales By Geography (USD MN)
  • Biotech & Microbiology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Technique (USD MN)
  • RNA Expression Market Sales By Geography (USD MN)
  • Promoter Analysis Market Sales By Geography (USD MN)
  • Protein Expression & Posttranslational Modification Analysis Market Sales By Geography (USD MN)
  • Global Gene Expression Analysis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gene Expression Analysis Report
  • Market Research Process
  • Market Research Methodology
  • Global Gene Expression Analysis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Process
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Capacity
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technique
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Process (USD MN)
  • Sample Collection Market Sales By Geography (USD MN)
  • Purification Market Sales By Geography (USD MN)
  • CDNA synthesis & conversion Market Sales By Geography (USD MN)
  • PCR Analysis Market Sales By Geography (USD MN)
  • Data analysis & interpretation Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • DNA Chips Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Capacity (USD MN)
  • Low- to Mid- Plex Market Sales By Geography (USD MN)
  • High-Plex Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Drug Discovery & Development Market Sales By Geography (USD MN)
  • Clinical Diagnostics Market Sales By Geography (USD MN)
  • Biotech & Microbiology Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Technique (USD MN)
  • RNA Expression Market Sales By Geography (USD MN)
  • Promoter Analysis Market Sales By Geography (USD MN)
  • Protein Expression & Posttranslational Modification Analysis Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218571

The global demand for Gene Expression Analysis Market is presumed to reach the market size of nearly USD 34.39 Billion by 2032 from USD 21.1 Billion in 2023 with a CAGR of 5.58% under the study period 2024-2032.

Gene expression analysis or GEA is the method of extracting data to investigate the behaviour of biological systems. Gene expression analysis combines various steps-transcription, RNA splicing, translation, and post-translational modification of a protein. This process is viewed as a sensitive indicator of biological activity in which a change in gene expression pattern results in the difference in the biological process. GEA has proven to be an effective tool in molecular biology research, which is used to understand the functioning of genes, diagnose diseases, and help in drug development.

MARKET DYNAMICS

The increased need for personalized medicine will likely influence the global gene expression analysis market over the projection timeframe. Besides, increased funding of associated programs is estimated to fuel market growth in upcoming years. Moreover, the rising prevalence of cancer patients globally has led to the rise in demand and application of gene expression analysis. Another significant factor likely to influence the growth of the global gene expression analysis market is the strong emphasis on laboratory research. Drug discovery and development are other factors that are likely to offer lucrative growth opportunities for market growth. Additionally, increased government funding in the direction of genomics has further propelled the market growth rate. However, factors such as lack of skilled labour, lack of awareness and high cost of instruments may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Gene Expression Analysis. The growth and trends of Gene Expression Analysis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Gene Expression Analysis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Process

  • Sample Collection
  • Purification
  • CDNA synthesis & conversion
  • PCR Analysis
  • Data analysis & interpretation

By Product

  • Kits & Reagents
  • DNA Chips
  • Others

By Capacity

  • Low- to Mid- Plex
  • High-Plex

By Application

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Biotech & Microbiology
  • Others

By Technique

  • RNA Expression
  • Promoter Analysis
  • Protein Expression & Posttranslational Modification Analysis
  • Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Gene Expression Analysis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Gene Expression Analysis market include Qiagen, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Agilent Technologies, GE Healthcare, Promega Corp., Luminex Corp., Takara Bio Inc., Danaher Corp., ELITechGroup, AutoGenomics, Biocartis NV, IntegraGen, Interpace Biosciences Inc., Fluidigm Corp. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. GENE EXPRESSION ANALYSIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Process
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Capacity
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By Technique
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY PROCESS

  • 5.1. Overview By Process
  • 5.2. Historical and Forecast Data Analysis By Process
  • 5.3. Sample Collection Historic and Forecast Sales By Regions
  • 5.4. Purification Historic and Forecast Sales By Regions
  • 5.5. CDNA synthesis & conversion Historic and Forecast Sales By Regions
  • 5.6. PCR Analysis Historic and Forecast Sales By Regions
  • 5.7. Data analysis & interpretation Historic and Forecast Sales By Regions

6. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Kits & Reagents Historic and Forecast Sales By Regions
  • 6.4. DNA Chips Historic and Forecast Sales By Regions
  • 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY CAPACITY

  • 7.1. Overview By Capacity
  • 7.2. Historical and Forecast Data Analysis By Capacity
  • 7.3. Low- to Mid- Plex Historic and Forecast Sales By Regions
  • 7.4. High-Plex Historic and Forecast Sales By Regions

8. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY APPLICATION

  • 8.1. Overview By Application
  • 8.2. Historical and Forecast Data Analysis By Application
  • 8.3. Drug Discovery & Development Historic and Forecast Sales By Regions
  • 8.4. Clinical Diagnostics Historic and Forecast Sales By Regions
  • 8.5. Biotech & Microbiology Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY TECHNIQUE

  • 9.1. Overview By Technique
  • 9.2. Historical and Forecast Data Analysis By Technique
  • 9.3. RNA Expression Historic and Forecast Sales By Regions
  • 9.4. Promoter Analysis Historic and Forecast Sales By Regions
  • 9.5. Protein Expression & Posttranslational Modification Analysis Historic and Forecast Sales By Regions

10. GLOBAL GENE EXPRESSION ANALYSIS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE GENE EXPRESSION ANALYSIS COMPANIES

  • 11.1. Gene Expression Analysis Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF GENE EXPRESSION ANALYSIS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Qiagen
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Quest Diagnostics Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. F. Hoffmann-La Roche Ltd.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Illumina Inc.
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. PerkinElmer Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Bio-Rad Laboratories
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Thermo Fisher Scientific Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Agilent Technologies
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. GE Healthcare
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Promega Corp.
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments
  • 12.13. Luminex Corp.
    • 12.13.1 Company Overview
    • 12.13.2 Company Revenue
    • 12.13.3 Products
    • 12.13.4 Recent Developments
  • 12.14. Takara Bio Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Company Revenue
    • 12.14.3 Products
    • 12.14.4 Recent Developments
  • 12.15. Danaher Corp.
    • 12.15.1 Company Overview
    • 12.15.2 Company Revenue
    • 12.15.3 Products
    • 12.15.4 Recent Developments
  • 12.16. ELITechGroup
    • 12.16.1 Company Overview
    • 12.16.2 Company Revenue
    • 12.16.3 Products
    • 12.16.4 Recent Developments
  • 12.17. AutoGenomics
    • 12.17.1 Company Overview
    • 12.17.2 Company Revenue
    • 12.17.3 Products
    • 12.17.4 Recent Developments
  • 12.18. Biocartis NV
    • 12.18.1 Company Overview
    • 12.18.2 Company Revenue
    • 12.18.3 Products
    • 12.18.4 Recent Developments
  • 12.19. IntegraGen
    • 12.19.1 Company Overview
    • 12.19.2 Company Revenue
    • 12.19.3 Products
    • 12.19.4 Recent Developments
  • 12.20. Interpace Biosciences Inc.
    • 12.20.1 Company Overview
    • 12.20.2 Company Revenue
    • 12.20.3 Products
    • 12.20.4 Recent Developments
  • 12.21. Fluidigm Corp
    • 12.21.1 Company Overview
    • 12.21.2 Company Revenue
    • 12.21.3 Products
    • 12.21.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies